XML 26 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Premiums and policy fees $ 8,384,604 $ 9,080,039
Ceded reinsurance premiums and policy fees (2,697,382) (2,680,050)
Net investment income 20,811,471 9,050,325
Other income 350,519 412,982
Revenue before net investment gains (losses) 26,849,212 15,863,296
Net investment gains (losses):    
Other-than-temporary impairments (5,000,000) (393,455)
Other realized investment gains, net 14,168,911 6,021,653
Change in fair value of equity securities 33,690,712 14,121,883
Total net investment gains 42,859,623 19,750,081
Total revenues 69,708,835 35,613,377
Benefits, claims and settlement expenses:    
Life 15,703,526 17,137,166
Ceded reinsurance benefits and claims (2,449,533) (2,380,366)
Annuity 1,029,156 993,937
Dividends to policyholders 311,400 324,543
Commissions (116,571) (121,287)
Amortization of cost of insurance acquired 688,348 714,970
Operating expenses 10,497,302 7,115,530
Interest expense 108,722 4,051
Total benefits and other expenses 25,772,350 23,788,544
Income before income taxes 43,936,485 11,824,833
Income tax expense 9,572,139 2,069,673
Net income 34,364,346 9,755,160
Net income attributable to noncontrolling interests (106,341) (92,097)
Net income attributable to common shareholders $ 34,258,005 $ 9,663,063
Amounts attributable to common shareholders:    
Basic income per share (in dollars per share) $ 10.81 $ 3.05
Diluted income per share (in dollars per share) $ 10.81 $ 3.05
Basic weighted average shares outstanding (in shares) 3,167,719 3,171,919
Diluted weighted average shares outstanding (in shares) 3,167,719 3,171,919